A Henry Ford Hospital study finds women with type 2 diabetes who take a usually prescribed class of medications to treat insulin resistance appears to be at a higher risk for developing bone fractures. After taking a thiazolidinedione (TZD) for one year, women are 50 percent more likely to have a bone fracture than patients not taking TZDs, as per study results. And those at the greatest risk for fractures from TZD use are women older than 65……..